Your Premiere Tampa Weight Loss Clinic - Offering The Newest Weight Loss Drugs

Leveraging over 35 years of expertise in bariatric weight loss medicine, South Tampa Regenerative invites you to join us as we tailor personalized healthcare programs, placing emphasis on safety, convenience, and affordability.

The NEWEST FDA-approved medication for weight loss is here!

Leveraging over 35 years of expertise in bariatric weight loss medicine, South Tampa Regenerative invites you to join us as we tailor personalized healthcare programs, placing emphasis on safety, convenience, and affordability.

What is Semaglutide?

Semaglutide, a key ingredient in medications like Ozempic and Wegovy, plays a crucial role in managing blood sugar levels and supporting weight management.

Ozempic and Wegovy:

Ozempic is designed to control blood sugar in individuals with type 2 diabetes, while Wegovy, with a higher semaglutide dose, targets overweight and obesity.

What is Tirzepatide?

Tirzepatide, a key ingredient in medications like Mounjaro and Zepbound, is a medication designed to address obesity and aid in weight loss. It has shown effectiveness in clinical studies, particularly at higher doses. Administered through a weekly injection, Tirzepatide has demonstrated remarkable results, with more than half of participants in certain studies experiencing over 20% body weight loss, a level unparalleled by most weight loss interventions. This medication represents a promising option for individuals seeking significant and sustained weight loss when combined with lifestyle changes

What is the difference between Semaglutide and Tirzepatide?

Studies indicate that both Semaglutide and Tirzepatide are effective in assisting individuals with obesity in losing weight and maintaining that weight loss as long as they remain on the medication. While both have shown significant weight loss results in overweight and obese participants when combined with lifestyle changes, Tirzepatide appears to yield more remarkable outcomes, particularly at the highest available dose.

Research on Semaglutide reveals that participants, when combining the weekly injection of 1mg with diet and exercise, lost an average of up to 7% of their body weight within one year, surpassing the placebo group by several percentage points. Notably, a weekly dose of 2.4 mg of Semaglutide demonstrated the potential for an average weight loss of 15%.

In comparison, Tirzepatide exhibited even more impressive results, with over half of the participants in one study losing over 20% of their body weight, especially on the highest dose of 15mg per week. This level of weight loss stands unparalleled by any intervention, except for bariatric surgery.

Who is a candidate for Semaglutide (Ozempic & Wegovy) and Tirzepatide (Zepbound & Mounjaro)

The FDA approves Ozempic, Wegovy, Zepbound, and Mounjaro for those with a BMI of 30 or greater. Individuals with a BMI of 27 or higher, along with conditions like type 2 diabetes and hypertension, may also qualify.

How does Semaglutide and Tirzepatide work?

Semaglutide and Tirzepatide regulate insulin levels, prompting the pancreas to release the right amount during elevated blood sugar. Additionally, they slow down stomach movement, reducing appetite and facilitating weight loss.

How do I take Semaglutide and Tirzepatide?

Administered through a weekly injection, starting with a low semaglutide or Tirzepatide dose, the dosage is gradually increased every four weeks under a healthcare provider's guidance. For more information on semaglutide and Tirzepatide benefits, contact the South Tampa Regenerative Medicine team and schedule an appointment today.

What kind of plans do we offer for advanced weightloss?

We offer tailored treatment plans to accommodate all weight loss goals and budgets. Whether you are looking for "Semaglutide Weightloss Near Me", or Wegovy Florida solutions, our advanced weightloss specialists are here to help!

What is Semaglutide?

Semaglutide, a key ingredient in medications like Ozempic and Wegovy, plays a crucial role in managing blood sugar levels and supporting weight management.

Ozempic and Wegovy:

Ozempic is designed to control blood sugar in individuals with type 2 diabetes, while Wegovy, with a higher semaglutide dose, targets overweight and obesity.

What is Tirzepatide?

Tirzepatide, a key ingredient in medications like Mounjaro and Zepbound, is a medication designed to address obesity and aid in weight loss. It has shown effectiveness in clinical studies, particularly at higher doses. Administered through a weekly injection, Tirzepatide has demonstrated remarkable results, with more than half of participants in certain studies experiencing over 20% body weight loss, a level unparalleled by most weight loss interventions. This medication represents a promising option for individuals seeking significant and sustained weight loss when combined with lifestyle changes

What is the difference between Semaglutide and Tirzepatide?

Studies indicate that both Semaglutide and Tirzepatide are effective in assisting individuals with obesity in losing weight and maintaining that weight loss as long as they remain on the medication. While both have shown significant weight loss results in overweight and obese participants when combined with lifestyle changes, Tirzepatide appears to yield more remarkable outcomes, particularly at the highest available dose.

Research on Semaglutide reveals that participants, when combining the weekly injection of 1mg with diet and exercise, lost an average of up to 7% of their body weight within one year, surpassing the placebo group by several percentage points. Notably, a weekly dose of 2.4 mg of Semaglutide demonstrated the potential for an average weight loss of 15%.

In comparison, Tirzepatide exhibited even more impressive results, with over half of the participants in one study losing over 20% of their body weight, especially on the highest dose of 15mg per week. This level of weight loss stands unparalleled by any intervention, except for bariatric surgery.

Who is a candidate for Semaglutide (Ozempic & Wegovy) and Tirzepatide (Zepbound & Mounjaro)

The FDA approves Ozempic, Wegovy, Zepbound, and Mounjaro for those with a BMI of 30 or greater. Individuals with a BMI of 27 or higher, along with conditions like type 2 diabetes and hypertension, may also qualify.

How does Semaglutide and Tirzepatide work?

Semaglutide and Tirzepatide regulate insulin levels, prompting the pancreas to release the right amount during elevated blood sugar. Additionally, they slow down stomach movement, reducing appetite and facilitating weight loss.

How do I take Semaglutide and Tirzepatide?

Administered through a weekly injection, starting with a low semaglutide or Tirzepatide dose, the dosage is gradually increased every four weeks under a healthcare provider's guidance. For more information on semaglutide and Tirzepatide benefits, contact the South Tampa Regenerative Medicine team and schedule an appointment today.

What kind of plans do we offer?

We offer tailored treatment plans to accommodate all weight loss goals and budgets.

Gain Access To...

Medical Care

24/7

South Tampa Regenerative Medicine clinical staff is here for your 24 hours a day, 7 days a week.  

Medical Care

24/7

Contact Us

Email: tyler@southtamparegenerative.com

Address: Tampa ,FL 33616

Phone: (813) 462-1450

Hours: Mon-Fri (8am-6pm)

advanced weightloss centre

Contact Us

Email: tyler@southtamparegenerative.com

Address: Tampa FL, 33616

Phone: (813) 462-1450

Hours: Mon-Fri (8am-6pm)

advanced weightloss centre